A review of the role of intermittent fasting in the management of inflammatory bowel disease.

"Declarations Ethics approval and consent to participate: Not applicable.Consent for publication: Not applicable.Author contributions:Celeste M. Lavallee: Conceptualization; Formal analysis; Investigation; Project administration; Writing – original draft; Writing – review & editing.Andreina Bruno: Conceptualization; Formal analysis; Investigation; Writing – original draft; Writing – review & editing.Christopher Ma: Formal analysis; Writing – review & editing.Maitreyi Raman: Conceptualization; Formal analysis; Supervision; Writing – review & editing.Funding: The authors received no financial support for the research, authorship, and/or publication of this article.Competing interests: The authors declare the following conflict of interests: CML, AB, and CM have no conflict of interest to declare. MR has received funding support from Crohn’s & Colitis Foundation Litwin IBD Pioneers Research Award to conduct a randomized controlled trial of intermittent fasting in patients with Crohn’s disease.Availability of data and materials: Not applicable. Competing interests: The authors declare the following conflict of interests: CML, AB, and CM have no conflict of interest to declare. MR has received funding support from Crohn’s & Colitis Foundation Litwin IBD Pioneers Research Award to conduct a randomized controlled trial of intermittent fasting in patients with Crohn’s disease."

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."